244 related articles for article (PubMed ID: 22151920)
21. Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
Müller SA; Mehrabi A; Rahbari NN; Warschkow R; Elbers H; Leowardi C; Fonouni H; Tarantino I; Schemmer P; Schmied BM; Büchler MW
Ann Surg Oncol; 2014 Jan; 21(1):155-64. PubMed ID: 23982253
[TBL] [Abstract][Full Text] [Related]
22. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
23. Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients.
Chau JK; Harris JR; Seikaly HR
J Otolaryngol Head Neck Surg; 2010 Oct; 39(5):516-22. PubMed ID: 20828514
[TBL] [Abstract][Full Text] [Related]
24. Impact of blood transfusions on recurrence and survival after rectal cancer surgery.
Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J
Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711
[TBL] [Abstract][Full Text] [Related]
25. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
[TBL] [Abstract][Full Text] [Related]
26. A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery.
Creasy TS; Veitch PS; Bell PR
Ann R Coll Surg Engl; 1987 May; 69(3):100-3. PubMed ID: 3605994
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
28. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
29. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer.
Lange MM; van Hilten JA; van de Watering LM; Bijnen BA; Roumen RM; Putter H; Brand A; van de Velde CJ;
Br J Surg; 2009 Jul; 96(7):734-40. PubMed ID: 19526613
[TBL] [Abstract][Full Text] [Related]
30. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A
Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
[TBL] [Abstract][Full Text] [Related]
31. Is dexamethasone associated with recurrence of ovarian cancer?
De Oliveira GS; McCarthy R; Turan A; Schink JC; Fitzgerald PC; Sessler DI
Anesth Analg; 2014 Jun; 118(6):1213-8. PubMed ID: 24299930
[TBL] [Abstract][Full Text] [Related]
32. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE
Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
Schwartz PE; Rutherford TJ; Chambers JT; Kohorn EI; Thiel RP
Gynecol Oncol; 1999 Jan; 72(1):93-9. PubMed ID: 9889037
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis.
Bristow RE; Puri I; Chi DS
Gynecol Oncol; 2009 Jan; 112(1):265-74. PubMed ID: 18937969
[TBL] [Abstract][Full Text] [Related]
35. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
[TBL] [Abstract][Full Text] [Related]
36. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
Woelber L; Jung S; Eulenburg C; Mueller V; Schwarz J; Jaenicke F; Mahner S
Eur J Surg Oncol; 2010 Jun; 36(6):583-8. PubMed ID: 20488646
[TBL] [Abstract][Full Text] [Related]
37. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
38. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
[TBL] [Abstract][Full Text] [Related]
39. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
